Federal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging
The decision in Maryland鈥檚 case could slow momentum for other states that are attempting to take action to curb high drug costs.
The independent source for health policy research, polling, and news.
1,001 - 1,020 of 1,305 Results
The decision in Maryland鈥檚 case could slow momentum for other states that are attempting to take action to curb high drug costs.
California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.
KHN's newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don't have to.
KHN鈥檚 Shefali Luthra offers insight into what federal and state officials are eyeing to help reduce addiction problems.
An abortion drug invented decades ago is being used to treat Cushing鈥檚 syndrome 鈥 and it鈥檚 bringing in tens of millions of dollars a year.
Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN鈥檚 "Newsmakers" program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.
Kaiser Health News launches 鈥淧re$cription for Power,鈥 a groundbreaking database to expose Big Pharma鈥檚 ties to patient groups.
The Centers for Disease Control and Prevention found antibiotic-resistant bacteria whose spread has 鈥渙utpaced鈥 efforts to contain them.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss President Donald Trump鈥檚 firing of David Shulkin, the secretary of Veterans Affairs, and Shulkin鈥檚 claim that he was forced out by those who want to privatize VA health care.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
Though opioid prescriptions appear to be on the聽decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid 鈥 a drug to treat hypothyroidism 鈥 came in at No. 1.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
How a prescription wiped out one woman鈥檚 health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don鈥檛) with medical costs.
A nationwide shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives 鈥 in some cases leading to dosage mistakes that may harm patients.
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years 鈥 but primarily among a white demographic.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it 鈥 or at least salvage its own reputation.
Last month鈥檚 budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
漏 2026 KFF